Grufity logoGrufity logo
ScreenerStocksFundsSectorsWatchlists
CAH

Cardinal Health Inc

CAH

106.18USD+0.31 (+0.29%)Delayed as of 07 Dec 2023, 02:35 pm
Watchlist

Market Summary

USD106.18+0.31
Delayedas of 07 Dec 2023, 02:35 pm
0.29%

CAH Alerts

  • 1 major insider sales recently.
  • Big fall in earnings (Y/Y)

CAH Stock Price

View Fullscreen

CAH RSI Chart

CAH Alerts

CAH Valuation

Market Cap

23.7B

Price/Earnings (Trailing)

90.88

Price/Sales (Trailing)

0.12

EV/EBITDA

16.57

Price/Free Cashflow

10.06

CAH Price/Sales (Trailing)

CAH Profitability

EBT Margin

0.31%

Return on Equity

-9.15%

Return on Assets

0.6%

Free Cashflow Yield

9.94%

CAH Fundamentals

CAH Revenue

Revenue (TTM)

210.2B

Revenue Y/Y

10.4%

Revenue Q/Q

2.45%

CAH Earnings

Earnings (TTM)

156.0M

Earnings Y/Y

-95.45%

Earnings Q/Q

107.81%

Price Action

52 Week Range

68.53106.30
(Low)(High)

Last 7 days

0.5%

Last 30 days

4.1%

Last 90 days

19.5%

Trailing 12 Months

33.3%

How does CAH drawdown profile look like?

CAH Financial Health

Current Ratio

1

Debt/Equity

-1.37

Debt/Cashflow

0.73

CAH Investor Care

Dividend Yield

2.14%

Dividend/Share (TTM)

1.98

Buy Backs (1Y)

6.91%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023198.7B205.0B210.2B0
2022176.8B181.4B187.0B193.0B
2021156.6B162.5B167.4B171.3B
2020153.6B152.9B154.6B156.5B
2019143.5B145.5B147.7B149.7B
2018134.4B136.8B139.4B141.9B
2017128.4B130.0B130.6B132.6B
2016117.7B121.5B125.5B127.2B
201597.9B102.5B106.5B112.4B
201493.6B91.1B90.6B93.9B
2013102.4B101.1B99.7B96.7B
2012107.6B107.6B106.6B104.8B
2011100.3B102.6B105.0B106.7B
201098.4B98.5B98.2B98.6B
200993.8B96.0B97.3B98.1B
2008087.4B89.6B91.7B
Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for CAH

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Dec 01, 2023
weitzman deborah
sold (taxes)
-68,317
107
-638
ceo, pharmaceutical segment
Dec 01, 2023
snow ola m
sold (taxes)
-40,904
107
-382
chief human resources officer
Dec 01, 2023
scherer mary c.
sold (taxes)
-23,236
107
-217
chief accounting officer
Nov 27, 2023
weitzman deborah
acquired
2,048,360
74.103
27,642
ceo, pharmaceutical segment
Nov 27, 2023
weitzman deborah
sold
-3,895,410
106
-36,642
ceo, pharmaceutical segment
Nov 15, 2023
hall patricia hemingway
acquired
-
-
1,965
-
Nov 15, 2023
brennan michelle
acquired
-
-
1,965
-
Nov 15, 2023
mundkur christine
acquired
-
-
1,965
-
Nov 15, 2023
mayer jessica l
sold (taxes)
-533,536
102
-5,185
chief legal/compliance officer
Nov 15, 2023
killefer nancy
acquired
-
-
1,965
-

1–10 of 50

Which funds bought or sold CAH recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Dec 04, 2023
TUCKER ASSET MANAGEMENT LLC
added
53.88
164,288
562,333
 0.15%
Dec 01, 2023
B. Riley Wealth Advisors, Inc.
reduced
-24.83
-453,761
993,409
 0.03%
Nov 28, 2023
IMA Wealth, Inc.
unchanged
-
-7,332
82,132
 0.02%
Nov 27, 2023
USA FINANCIAL FORMULAS
unchanged
-
-171
1,910
 -%
Nov 27, 2023
TRUST CO OF VERMONT
reduced
-21.93
-371,725
940,434
 0.06%
Nov 24, 2023
EP Wealth Advisors, LLC
new
-
258,175
258,175
 -%
Nov 24, 2023
DEUTSCHE BANK AG\
added
64.66
30,199,200
89,222,300
 0.06%
Nov 22, 2023
KBC Group NV
unchanged
-
-
23,634,000
 0.10%
Nov 22, 2023
Public Sector Pension Investment Board
added
12.19
69,084
2,374,700
 0.02%
Nov 21, 2023
TOMPKINS FINANCIAL CORP
unchanged
-
-13,872
155,408
 0.02%

1–10 of 44

Latest Funds Activity

Are funds buying CAH calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CAH
No. of Funds

Schedule 13G FIlings of Cardinal Health Inc

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
price t rowe associates inc /md/
1.9%
4,994,087
SC 13G/A
Feb 09, 2023
vanguard group inc
11.95%
31,320,204
SC 13G/A
Feb 06, 2023
state street corp
6.70%
17,568,683
SC 13G/A
Jan 26, 2023
blackrock inc.
11.3%
29,572,939
SC 13G/A
Jan 20, 2023
blackrock inc.
11.3%
29,572,939
SC 13G/A
Sep 08, 2022
blackrock inc.
10.6%
28,946,151
SC 13G
Feb 14, 2022
price t rowe associates inc /md/
5.3%
15,028,767
SC 13G
Feb 10, 2022
state street corp
7.59%
21,384,169
SC 13G/A
Feb 09, 2022
vanguard group inc
12.72%
35,841,618
SC 13G/A
Feb 01, 2022
blackrock inc.
7.8%
21,999,306
SC 13G/A

Recent SEC filings of Cardinal Health Inc

View All Filings
Date Filed Form Type Document
Dec 05, 2023
4
Insider Trading
Dec 05, 2023
4
Insider Trading
Dec 05, 2023
4
Insider Trading
Dec 04, 2023
144
Notice of Insider Sale Intent
Nov 29, 2023
4
Insider Trading
Nov 27, 2023
144
Notice of Insider Sale Intent
Nov 16, 2023
4
Insider Trading
Nov 16, 2023
4
Insider Trading
Nov 16, 2023
4
Insider Trading
Nov 16, 2023
4
Insider Trading

Peers (Alternatives to Cardinal Health Inc)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
ABT
182.7B
40.0B
 10.53% 1.10%
35.4
4.57
 -11.26% -34.57%
BDX
71.3B
19.4B
 -9.91% -3.76%
44.09
3.79
 2.66% -16.58%
BAX
18.2B
15.0B
 4.18% -29.75%
7.01
1.21
 3.01% 209.09%
ALGN
16.6B
3.8B
 9.66% 16.57%
45.78
4.36
 -1.48% -28.97%
MID-CAP
HSIC
9.2B
12.7B
 12.76% -12.43%
20.62
0.72
 0.68% -30.25%
BIO
9.0B
2.7B
 7.54% -22.26%
-56.74
3.32
 -3.01% 97.36%
ATR
8.3B
3.4B
 0.99% 18.16%
29.54
2.41
 3.13% 18.17%
XRAY
6.8B
3.9B
 12.78% 6.97%
-31.29
1.73
 -2.62% 73.28%
AXNX
2.9B
342.6M
 7.26% -12.48%
-242.59
8.48
 42.19% 84.14%
PDCO
2.5B
6.6B
 -13.73% -8.33%
12.42
0.38
 2.61% 0.62%
SMALL-CAP
AHCO
1.1B
3.1B
 0.24% -60.88%
-2.68
0.37
 7.95% -550.16%
ANIK
321.6M
163.3M
 3.63% -28.72%
-13.09
1.97
 7.14% -56.09%
ANGO
272.3M
335.9M
 0.60% -44.41%
42.24
0.81
 4.71% 116.39%
APYX
77.6M
50.3M
 -12.16% 23.08%
-5.12
1.54
 3.23% 20.81%
AEMD
5.3M
3.8M
 10.99% -46.93%
-0.45
1.39
 17.30% 10.67%

Cardinal Health Inc News

Latest updates
Nasdaq • 07 Dec 2023 • 02:40 pm • 4 hours ago
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
InvestorsObserver • 07 Dec 2023 • 11:30 am • 8 hours ago
Is Cardinal Health Inc (CAH) the Top Pick in the Medical Distribution Industry?
Nasdaq • 06 Dec 2023 • 09:00 pm • 22 hours ago
CAH Factor-Based Stock Analysis
Best Stocks • 06 Dec 2023 • 05:01 pm • 26 hours ago
Medical Device Recall Initiated by Nurse Assist LLC for Cardinal ...
MarketBeat • 06 Dec 2023 • 01:30 pm • 30 hours ago
Nuveen Asset Management LLC Sells 417252 Shares of Cardinal ...
MarketBeat • 05 Dec 2023 • 07:31 pm • 2 days ago
Cardinal Health, Inc. (NYSE:CAH) Stake Boosted by Lbp Am Sa
Zacks Investment Research • 04 Dec 2023 • 01:00 pm • 3 days ago
McKesson (MCK) Announces Availability of FDA-Cleared Drug
Yahoo Finance • 04 Dec 2023 • 11:17 am • 3 days ago
Zacks.com featured highlights Cboe Global Markets, Cardinal ...
Nasdaq • 01 Dec 2023 • 04:16 pm • 6 days ago
Nevro's (NVRO) Latest Buyout to Boost SI Joint Pain Treatment
MarketBeat • 30 Nov 2023 • 06:33 pm • 7 days ago
Renaissance Technologies LLC Acquires 735004 Shares of ...
Nasdaq • 30 Nov 2023 • 04:03 pm • 7 days ago
January 2024 Options Now Available For Cardinal Health (CAH)
Simply Wall St • 29 Nov 2023 • 07:45 pm • 7 days ago
Cardinal Health's (NYSE:CAH) investors will be pleased with their impressive 116% return over the last three years
Yahoo Finance • 29 Nov 2023 • 06:04 pm • 8 days ago
Insider Sell: CEO Deborah Weitzman Offloads Shares of Cardinal ...
Yahoo Finance • 29 Nov 2023 • 02:50 pm • 8 days ago
Why This 1 Momentum Stock Could Be a Great Addition to Your ...
Yahoo Finance • 27 Nov 2023 • 02:15 pm • 10 days ago
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to ...

Financials for Cardinal Health Inc

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue2.5%54,76353,45350,48751,46949,60347,10344,83645,45743,96842,58639,27541,54139,06536,68939,15739,73537,34137,35335,22837,74035,213
Gross Profit-3.2%1,7681,8271,7851,6631,6141,6051,6821,6161,6421,4751,8121,7761,7151,5901,8851,7141,6791,6741,7641,7301,667
  S&GA Expenses-5.5%1,1971,2671,1791,1911,1971,1551,1371,1511,1141,1291,1201,1471,1371,1371,1651,1631,1071,1681,0971,0641,155
EBITDA Margin-100.0%-0.01*0.01*0.00*0.00*0.00*0.00*0.00*0.01*0.01*0.01*0.01*0.01*-0.02*-0.02*------
Interest Expenses-6.7%14.0015.0028.0025.0025.0034.0038.0037.0040.0044.0045.0046.0045.0049.0060.0063.0066.0067.0075.0076.0077.00
Income Taxes-117.1%-32.00187197-7.00-1.00-1651,253-1,02297.004.00320-203-410107-127-59.00-42344.0074.00126142
Earnings Before Taxes-121.5%-26.00121544-137110-28.00-137-973369119440427-663815478279-5,344239370407736
EBT Margin-100.0%-0.00*0.00*0.00*-0.01*0.00*0.00*0.00*0.01*0.00*0.01*0.01*0.01*-0.02*-0.03*------
Net Income107.8%5.00-64.00345-130110138-1,39149.00271116119629-253656350220-4,922194296280593
Net Income Margin-100.0%-0.00*0.00*-0.01*-0.01*-0.01*-0.01*0.00*0.01*0.00*0.01*0.01*0.01*-0.02*-0.03*------
Free Cashflow-100.0%-6411,252512-47.002,828-5011,121-7135391771,1211921041,586------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets0.7%43,71043,41743,37744,48243,38743,87842,11143,68042,99344,45343,87444,71941,72740,76641,14841,04239,17940,96340,80940,46240,011
  Current Assets2.5%34,68833,83333,49734,59632,69632,93530,88431,84729,73131,04830,36230,11327,03025,94025,84825,73623,71525,74725,58225,09124,445
    Cash Equivalents-4.7%3,8544,0433,9903,6543,4924,7172,3563,1612,4633,4073,4993,7372,7462,7712,3291,6591,2122,5313,4382,1822,045
  Inventory6.6%16,98715,94016,62017,26315,89115,63615,49314,94114,72014,59414,32914,44313,43913,19812,80813,79912,45812,82212,62213,03712,481
  Net PPE-0.9%2,4412,4622,3622,3412,3392,3612,2982,3212,3362,3602,3152,3862,3692,3662,2992,3012,3242,3562,3222,3762,436
  Current Liabilities4.0%35,06533,70632,50333,21231,55930,55028,71527,72926,49927,62425,32325,75024,01623,61524,67124,89022,54924,10923,91923,82423,057
  Long Term Debt-0.5%3,8903,9094,7084,6854,6894,7354,7515,3425,3535,3656,7156,7206,7286,7656,7546,7427,3607,5797,6297,5997,999
Shareholder's Equity-22.4%-3,490-2,851---1,780-706-1,0021,3961,7941,7941,9751,4251,7921,2061,0029036,3306,2326,0435,913
  Retained Earnings-22.5%-654-534-342-560-301-280-2811,2451,3351,2051,2331,2557711,1706564493715,4345,3865,2335,097
Shares Outstanding---256261271-275279287-292294293-292292296-298299305
Minority Interest0%1.001.002.001.001.003.004.004.003.003.004.004.003.003.003.003.003.002.002.00--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations-36.5%5458581,36159723.002,992-4191,195-6466652771,2172702401,676697-6535061,480371365
  Share Based Compensation7.4%29.0027.0021.0025.0023.0016.0023.0018.0024.005.0033.0023.0028.0022.0027.0021.0020.0018.0023.0022.0019.00
Cashflow From Investing69.4%-63.00-206-91.00-87.00-70.00-204-44.00-47.00862-88.00-99.00-97.00-94.00742-98.00-78.00-73.00-173-84.00-84.00679
Cashflow From Financing-12.5%-666-592-934-362-1,163-415-340-444-1,264-649-324-146-198-528-912-175-585-1,243-142-144-764
  Dividend Payments4.0%131126128129142134136140149141143143146141141141146142142143150
  Buy Backs0%5005002502501,000-200300500-200-----350---600

CAH Income Statement

2023-09-30
Condensed Consolidated Statements of Earnings - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]  
Revenue$ 54,763$ 49,603
Cost of Goods and Services Sold52,99547,989
Gross margin1,7681,614
Operating expenses:  
Distribution, selling, general and administrative expenses1,1971,197
Restructuring and employee severance2529
Amortization and other acquisition-related costs6471
Impairments and (gain)/loss on disposal of assets, net537153
Litigation (recoveries)/charges, net(41)27
Operating earnings/(loss)(14)137
Other (income)/expense, net(2)2
Interest expense, net1425
Earnings/(loss) before income taxes(26)110
Benefit from income taxes(32)(1)
Net earnings6111
Less: Net earnings attributable to noncontrolling interests(1)(1)
Net earnings attributable to Cardinal Health, Inc.$ 5$ 110
Earnings per common share attributable to Cardinal Health, Inc.:  
Basic (in shares)$ 0.02$ 0.41
Diluted (in shares)$ 0.02$ 0.40
Weighted-average number of common shares outstanding:  
Basic (in shares)249271
Diluted (in shares)250273
Cash dividends declared per common share$ 0.5006$ 0.4957

CAH Balance Sheet

2023-09-30
Condensed Consolidated Balance Sheets - USD ($)
shares in Thousands, $ in Millions
Sep. 30, 2023
Jun. 30, 2023
Current assets:  
Cash and equivalents$ 3,854$ 4,043
Trade receivables, net11,26511,344
Inventories, net16,98715,940
Prepaid expenses and other2,5822,362
Assets held for sale0144
Total current assets34,68833,833
Property and equipment, net2,4412,462
Goodwill and other intangibles, net5,4326,081
Other Assets1,1491,041
Total assets43,71043,417
Current liabilities:  
Accounts Payable, Current31,54029,813
Current portion of long-term obligations and other short-term borrowings788792
Other accrued liabilities2,7373,059
Liabilities related to assets held for sale042
Total current liabilities35,06533,706
Long-term obligations, less current portion3,8903,909
Deferred income taxes and other liabilities$ 8,245$ 8,653
Preferred shares, without par value:  
Preferred Stock, Shares Authorized500500
Preferred Stock, Shares Issued00
Preferred Stock, Value, Issued$ 0$ 0
Common shares, without par value:  
Common Stock, Shares Authorized755,000755,000
Common Stock, Shares, Issued327,000327,000
Common Stock, Value, Issued$ 2,728$ 2,747
Accumulated deficit(654)(534)
Treasury Stock, Value$ (5,400)$ (4,914)
Treasury Stock, Shares80,00076,000
Accumulated other comprehensive loss$ (165)$ (151)
Total Cardinal Health, Inc. shareholders' deficit(3,491)(2,852)
Noncontrolling interests11
Total shareholders' equity(3,490)(2,851)
Total liabilities and shareholders’ deficit$ 43,710$ 43,417

About Cardinal Health Inc

CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
 CEO
 WEBSITEwww.cardinalhealth.com
 EMPLOYEES47040

Cardinal Health Inc Frequently Asked Questions

What is the ticker symbol for Cardinal Health Inc? What does CAH stand for in stocks?

CAH is the stock ticker symbol of Cardinal Health Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Cardinal Health Inc (CAH)?

As of Wed Dec 06 2023, market cap of Cardinal Health Inc is 23.72 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CAH stock?

You can check CAH's fair value in chart. The fair value of Cardinal Health Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Cardinal Health Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CAH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Cardinal Health Inc a good stock to buy?

The fair value guage provides a quick view whether CAH is over valued or under valued. Whether Cardinal Health Inc is cheap or expensive depends on the assumptions which impact Cardinal Health Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CAH.

What is Cardinal Health Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 06 2023, CAH's PE ratio (Price to Earnings) is 90.88 and Price to Sales (PS) ratio is 0.12. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CAH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Cardinal Health Inc's stock?

In the past 10 years, Cardinal Health Inc has provided 0.08 (multiply by 100 for percentage) rate of return.